Thought Leader Series: Professor John Zalcberg Rare Cancers Australia 33:03 1 year ago 310 Скачать Далее
Dr. John Zalcberg on Regorafenib in Refractory Advanced Oesophago-Gastric Cancer Patients Targeted Oncology 1:00 8 years ago 146 Скачать Далее
OCA Symposium: Professor John Zalcberg on the Ovarian Cancer Clinical Quality Registry Ovarian Cancer Australia 20:49 6 years ago 131 Скачать Далее
The Role of Consumers in Clinical Trials: Professor John R Zalcberg SydneyLHD 31:54 5 years ago 74 Скачать Далее
Professor David Goldstein on receiving the AGITG John Zalcberg OAM award GI Cancer Institute 1:59 7 years ago 97 Скачать Далее
Debate over access to new cancer drugs ABC News 24 interview with Prof John Zalcberg Cancer Drugs Alliance 5:39 9 years ago 145 Скачать Далее
Randomized Phase II Study of Regorafenib in Refractory AOGC Targeted Oncology 1:42 8 years ago 31 Скачать Далее
Being Part of the New Health Frontier - An Industry Response to Parliamentary Report Australian Health Journal 20:30 2 years ago 1 739 Скачать Далее
Medicines NZ Parliamentary Dinner 2018 Highlights Medicines New Zealand 1:52 5 years ago 60 Скачать Далее
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperati... | RTCL.TV STEM RTCL TV 0:34 9 months ago 24 Скачать Далее
NHMRC Clinical Trials Centre 30th Anniversary Symposium Sarah Munro 2:20 5 years ago 111 Скачать Далее
Dr. Solomon on the Results of the Phase 3 CROWN Study in ALK-Positive NSCLC OncLive 1:26 3 years ago 270 Скачать Далее
EmpowerED webinar - Advances in Pancreatic Cancer Research PanKind Australian Pancreatic Cancer Foundation 1:13:24 3 years ago 72 Скачать Далее
2019 Avner Foundation Innovation Grant recipients PanKind Australian Pancreatic Cancer Foundation 0:45 4 years ago 18 Скачать Далее
